These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2666570)

  • 21. Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line.
    Ananaba GA; Anderson LJ
    J Virol; 1991 Sep; 65(9):5052-60. PubMed ID: 1870211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytotoxic T cell activity against the 22-kDa protein of human respiratory syncytial virus (RSV) is associated with a significant reduction in pulmonary RSV replication.
    Nicholas JA; Rubino KL; Levely ME; Meyer AL; Collins PL
    Virology; 1991 Jun; 182(2):664-72. PubMed ID: 2024493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune response to respiratory syncytial virus: prevention of syncytia formation by human serum during in vitro infection.
    Faden H; Lin T; Hong JJ; Ogra PL
    Pediatr Res; 1984 Oct; 18(10):987-91. PubMed ID: 6387611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immunologic response to infection with respiratory syncytial virus in infants.
    McIntosh K; Masters HB; Orr I; Chao RK; Barkin RM
    J Infect Dis; 1978 Jul; 138(1):24-32. PubMed ID: 355574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Broadly Reactive Anti-Respiratory Syncytial Virus G Antibodies from Exposed Individuals Effectively Inhibit Infection of Primary Airway Epithelial Cells.
    Cortjens B; Yasuda E; Yu X; Wagner K; Claassen YB; Bakker AQ; van Woensel JBM; Beaumont T
    J Virol; 2017 May; 91(10):. PubMed ID: 28275185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody response to respiratory syncytial virus structural proteins in children with acute respiratory syncytial virus infection.
    Vainionpää R; Meurman O; Sarkkinen H
    J Virol; 1985 Mar; 53(3):976-9. PubMed ID: 3973971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement activation by respiratory syncytial virus-infected cells.
    Edwards KM; Snyder PN; Wright PF
    Arch Virol; 1986; 88(1-2):49-56. PubMed ID: 3954599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic T cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen.
    Pemberton RM; Cannon MJ; Openshaw PJ; Ball LA; Wertz GW; Askonas BA
    J Gen Virol; 1987 Aug; 68 ( Pt 8)():2177-82. PubMed ID: 3497222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Attenuation of respiratory syncytial virus-induced and RIG-I-dependent type I IFN responses in human neonates and very young children.
    Marr N; Wang TI; Kam SH; Hu YS; Sharma AA; Lam A; Markowski J; Solimano A; Lavoie PM; Turvey SE
    J Immunol; 2014 Feb; 192(3):948-57. PubMed ID: 24391215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppression of the antibody response to respiratory syncytial virus (RSV) by pre-existing serum antibodies: partial prevention by topical infection of the respiratory tract with vaccinia virus-RSV recombinants.
    Murphy BR; Collins PL; Lawrence L; Zubak J; Chanock RM; Prince GA
    J Gen Virol; 1989 Aug; 70 ( Pt 8)():2185-90. PubMed ID: 2671259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus.
    Bangham CR; McMichael AJ
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):9183-7. PubMed ID: 3097646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease.
    Murphy BR; Sotnikov A; Paradiso PR; Hildreth SW; Jenson AB; Baggs RB; Lawrence L; Zubak JJ; Chanock RM; Beeler JA
    Vaccine; 1989 Dec; 7(6):533-40. PubMed ID: 2692334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-induced complement activation and neutrophil-mediated cytotoxicity against respiratory syncytial virus (RSV).
    Kaul TN; Faden H; Baker R; Ogra PL
    Clin Exp Immunol; 1984 Jun; 56(3):501-8. PubMed ID: 6744659
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory syncytial virus infection of human mononuclear leukocytes in vitro and in vivo.
    Domurat F; Roberts NJ; Walsh EE; Dagan R
    J Infect Dis; 1985 Nov; 152(5):895-902. PubMed ID: 2931491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bronchiolitis caused by respiratory syncytial virus in very young infants and transmitted maternal antibodies].
    Attree O; Tourangeau F; De Saint-Maur G; Alvarez-Vega M; Nicolas JC; Garbarg-Chenon A; Bricout F
    Arch Fr Pediatr; 1988 Dec; 45(10):791-3. PubMed ID: 3071286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro cell-dependent lysis of respiratory syncytial virus-infected cells mediated by antibody from local respiratory secretions.
    Cranage MP; Gardner PS; McIntosh K
    Clin Exp Immunol; 1981 Jan; 43(1):28-35. PubMed ID: 7018759
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for admission and the role of respiratory syncytial virus-specific cytotoxic T-lymphocyte responses in children with acute bronchiolitis.
    Jeena PM; Ayannusi OE; Annamalai K; Naidoo P; Coovadia HM; Guldner P
    S Afr Med J; 2003 Apr; 93(4):291-4. PubMed ID: 12806723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells.
    Muñoz JL; McCarthy CA; Clark ME; Hall CB
    J Virol; 1991 Aug; 65(8):4494-7. PubMed ID: 2072460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection.
    DiNapoli JM; Murphy BR; Collins PL; Bukreyev A
    Virol J; 2008 Sep; 5():105. PubMed ID: 18816384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.